InsiderTrades

Form 4 for MRNA Moderna

Accepted 2025-05-01 00:00:00 ET · period of report 2025-04-30 · accession 0001127602-25-012943 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-01 2025-04-30 MRNA Rubenstein David M. Dir M - OptEx — +677 677 New —
DM 2025-05-01 2025-04-30 MRNA Rubenstein David M. Dir A - Grant $0.00 +20.9K 12.8K New $0
D 2025-05-01 2025-04-30 MRNA Rubenstein David M. Dir M - OptEx $0.00 -677 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-04-30 M A 677 — 677 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Derivative Restricted Stock Units 2025-04-30 A A 8,116 $0.00 8,116 D — · — to — 8,116 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
3 Derivative Stock Option (Right to Buy) 2025-04-30 A A 12,756 $0.00 12,756 D $28.54 · — to 2035-04-30 12,756 Common Stock (F3) This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
4 Derivative Restricted Stock Units 2025-04-30 M D 677 $0.00 0 D — · — to — 677 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The shares subject to this restricted stock unit award vested in full on April 30, 2025.